Dose-Ranging Efficacy and Safety Study of Albuterol Multidose Dry Powder Inhaler (MDPI) vs Albuterol Hydrofluoroalkane (HFA) and Placebo MDPI in Children With Asthma

被引：0

作者：

Qaqundah, Paul Y. ^{[1
]}

Taveras, Herminia ^{[2
]}

Iverson, Harald ^{[2
]}

Shore, Paul ^{[3
]}

Shah, Tushar P. ^{[3
]}

机构：

[1] Pediat Care Med Grp Inc, Huntington Beach, CA USA

[2] Teva Pharmaceut, Miami, FL USA

[3] Teva Pharmaceut, Frazer, PA USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2016年 / 137卷 / 02期

关键词：

D O I：

10.1016/j.jaci.2015.12.1277

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

686

引用

页码：AB211 / AB211

页数：1

共 36 条

[1] Efficacy and Safety of Albuterol Multidose Dry Powder Inhaler (MDPI) Versus Placebo in Children With Asthma
LaForce, Craig
Taveras, Herminia
Iverson, Harald
Shore, Paul
Shah, Tushar P.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB209 - AB209
[2] Albuterol multidose dry powder inhaler and albuterol hydrofluoroalkane versus placebo in children with persistent asthma
Qaqundah, Paul Y.
Taveras, Herminia
Iverson, Harald
Shore, Paul
ALLERGY AND ASTHMA PROCEEDINGS, 2016, 37 (05) : 350 - 358
[3] Duration Of Response And Time To Response Of Albuterol Multidose Dry Powder Inhaler Vs Albuterol Hydrofluoroalkane And Placebo In Children With Asthma
Qaqundah, P. Y.
Taveras, H.
Iverson, H.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
[4] Pharmacokinetics and pharmacodynamics of albuterol multidose dry powder inhaler and albuterol hydrofluoroalkane in children with asthma
Ratnayake, Anoshie
Taveras, Herminia
Iverson, Harald
Shore, Paul
ALLERGY AND ASTHMA PROCEEDINGS, 2016, 37 (05) : 370 - 375
[5] Albuterol multidose dry powder inhaler efficacy and safety versus placebo in children with asthma
LaForce, Craig
Taveras, Herminia
Iverson, Harald
Shore, Paul
ALLERGY AND ASTHMA PROCEEDINGS, 2017, 38 (01) : 28 - 37
[6] PHARMACOKINETICS AND PHARMACODYNAMICS OF ALBUTEROL MULTIDOSE DRY POWDER INHALER AND ALBUTEROL HYDROFLUOROALKANE ADMINISTERED TO CHILDREN WITH ASTHMA
Ratnayake, A.
Taveras, H.
Iverson, H.
Shore, P.
Shah, T.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : A53 - A53
[7] CUMULATIVE DOSE COMPARISON OF THE EFFICACY AND SAFETY OF ALBUTEROL-MULTIDOSE DRY POWDER INHALER AND ALBUTEROL-HYDROFLUOROALKANE METERED DOSE INHALER IN ADULTS WITH ASTHMA.
Miller, D.
Wayne, D.
Ferro, T.
Taveras, H.
Iverson, H.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A46 - A46
[8] Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler (FS MDPI) Compared with Fluticasone Propionate (Fp) Mdpi and FS DPI in Subjects with Persistent Asthma
Steinfeld, Jonathan
Yiu, Gloria
Miller, S. David
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB6 - AB6
[9] EFFICACY OF ALBUTEROL MULTIDOSE DRY POWDER INHALER VERSUS PLACEBO IN SUBJECTS 12 YEARS OF AGE AND OLDER WITH PERSISTENT ASTHMA.
Raphael, G.
Taveras, H.
Iverson, H.
O'Brien, C.
Miller, D.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A45 - A46
[10] Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma
Raphael, Gordon
Taveras, Herminia
Iverson, Harald
O'Brien, Christopher
Miller, David
JOURNAL OF ASTHMA, 2016, 53 (02) : 187 - 193

← 1 2 3 4 →